Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 28, 2026; 32(44): 117819
Published online Nov 28, 2026. doi: 10.3748/wjg.117819
Published online Nov 28, 2026. doi: 10.3748/wjg.117819
Figure 9 Spearman’s correlation analyses between the relative abundance of gut microbiota at the genus level and bile acids.
A: The correlations between gut microbiota and bile acids between the control and α-naphthylisothiocyanate (ANIT) group; B: The correlations between gut microbiota and bile acids between the ANIT and emodin-ANIT group. Data were analyzed via two-tailed test of significance. aP < 0.05 vs control group, bP < 0.01 vs control group, cP < 0.001 vs control group, dP < 0.05 vs α-naphthylisothiocyanate group, eP < 0.01 vs α-naphthylisothiocyanate group, and fP < 0.001 vs α-naphthylisothiocyanate group.
- Citation: Wang CX, Wang LM, Fu ZF, Zhao X, Han LF, Lou YF. Emodin ameliorates cholestatic liver injury by regulating bile acid metabolism and gut microbiota in mice. World J Gastroenterol 2026; 32(44): 117819
- URL: https://www.wjgnet.com/1007-9327/full/v32/i44/117819.htm
- DOI: https://dx.doi.org/10.3748/wjg.117819